CClinicalTrials.gg
Sign In
Status unknownNCT02675010Updated Mar 16, 2016

Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study

An interventional study of ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY in Helicobacter Pylori, Gastric Antrum and CORPUS BIOPSIES, sponsored by Mansoura University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2016-03-16.

Sponsored by Mansoura University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Feb 2016), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Sex
All
01

Study summary

There are controversies about the best sites -biopsy based -tests for H pylori associated gastritis. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

Read the detailed description

. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia. 400 patients with dyspepsia are planned to be enrolled in this study. in addition to the routine antral biospy, corpus biospies are taken to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

02

Conditions studied

  • Helicobacter Pylori
  • Gastric Antrum
  • CORPUS BIOPSIES
03

In context

Gastritis

196 studies on the registry are indexed under Gastritis; 42 are open to participants now.

This study's planned enrollment of 400 is above the median of 200 across 113 interventional studies indexed under Gastritis.

Browse Gastritis studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients included in this study are those with peptic ulcer disease, previous upper gastrointestinal surgery, a known or a suspected past history of H.pylori eradication therapy, a personal or first-degree family history of gastric cancer

Exclusion criteria

Exclusion Criteria:

  • those having received antibiotic or proton pump inhibitor treatment one month beforehand
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Other
    ENDOSCOPIC GASTRIC BIOPSIES

    ENDOSCOPIC BIOPSEIS TAKEN FROM BOTH ANTRUM AND CORPUS FOR H PYLORI DETECTION

    Other: ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Interventions

  • OtherENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

    ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

06

What researchers measure

Primary outcomes

  1. H PYLORI POSITIVITY

    Time frame: 2 YEARS

07

Study locations

1 site
  • Mansoura University Hospital
    Mansoura, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02675010
Lead sponsor
Mansoura University
Responsible party
MOHAMED ABDELLATIF (ass. prof., Mansoura University) — Principal investigator
First posted
Feb 5, 2016
Start date
Jun 2014
Primary completion
Jun 2016 (estimated)
Completion
Jun 2016 (estimated)
Last update
Mar 16, 2016

Study contacts

MOHAMED ABDELLATIF, ASS PROF
study chair · MANSOURA FACULTY OF MEDICINE

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Gastritis→

Other studies from this sponsor

Mansoura University

Start the discussion